cTnI/Myo/CK-MB Combo Rapid Test

A combination rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin (Myo), and creatine kinase-MB (CK-MB). This multiplex test supports cardiac biomarker assessment for heart attack and myocardial injury detection.

A multiplex rapid test for simultaneously detecting cardiac troponin I, myoglobin, and creatine kinase-MB. Provides comprehensive cardiac marker assessment for heart damage and stress evaluation.

Rapid test kit for simultaneous detection of cardiac troponin I (cTnI), myoglobin, and creatine kinase-MB (CK-MB) markers. Designed for quick diagnosis of acute myocardial infarction and cardiac injury in clinical and emergency settings. Delivers results in minutes to support timely patient management.

Immunofluorescence-based combined test kit for simultaneous detection of cardiac biomarkers cTnI, CK-MB, and myoglobin. Designed for rapid cardiac injury assessment in acute coronary syndrome diagnosis and risk stratification. Enables multi-marker analysis from a single sample for improved clinical decision-making.

A multiplex rapid test cassette for simultaneous detection of cardiac biomarkers including troponin I, myoglobin, and creatine kinase-MB. The test aids in rapid cardiac assessment and myocardial infarction diagnosis at the point of care.

Uses highly specific antigen-antibody reactions and immunochromatographic analysis technology with colloidal gold-labeled rapid solid-phase immunochromatography to qualitatively detect CTnI, CK-MB, and MYO markers in whole blood, serum, and plasma. The simultaneous detection of three markers provides greater clinical reference significance.

A combination test measuring cardiac troponin I, cardiac fatty acid binding protein (H-FABP), and creatine kinase-MB (CK-MB). This multi-biomarker assay provides rapid assessment of myocardial necrosis and injury for early diagnosis of acute myocardial infarction.

Quantitative fluorescence immunoassay test panels for cTnI, NT-proBNP, CK-MB, and D-Dimer that provide highly accurate concentration readouts within 15 minutes. Designed to empower chest pain centers with rapid, accurate results crucial for acute myocardial infarction intervention.

A quantitative test kit for simultaneous measurement of cardiac troponin I (cTnI), creatine kinase-MB (CK-MB), and myoglobin (MYO) levels in patient samples using TRFIA methodology.

High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.

Diagnostic test for high-sensitivity cardiac troponin I (Hs-cTnI) and other cardiac markers. Provides rapid assessment for acute coronary syndrome evaluation.

Rapid immunochromatographic assay for detection of cardiac biomarkers including troponin and myoglobin. Enables quick assessment of myocardial injury in emergency and clinical settings.